Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

3.77
Delayed Data
As of 10:28am ET
 +0.08 / +2.17%
Today’s Change
2.93
Today|||52-Week Range
8.00
-26.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues2.3M2.9M3.3M2.6M
 
 
 
 
 
Cost of Goods Sold1.2M3.1M3.3M3.0M
 
 
 
 
 
Depreciation And Amortization116.0K117.3K117.9K118.1K
 
 
 
 
 
 
Operating ExpensesGross Income927.5K-280.5K-77.2K-466.9K
 
 
 
 
 
General Expenses6.4M3.5M3.9M5.5M
 
 
 
 
 
Research And Development3.4M1.7M583.4K1.2M
 
 
 
 
 
Total Operating Expenses7.8M6.7M7.3M8.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.5M-3.7M-3.9M-5.9M
 
 
 
 
 
Interest Expense On Debt538.0K606.0K628.2K618.5K
 
 
 
 
 
Other Expenses4.5K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.0M-4.3M-4.6M-6.5M
 
 
 
 
 
Net Income-6.0M-4.3M-4.6M-6.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.1M12.9M12.9M12.9M
 
 
 
 
 
Shares To Calculate EPS Diluted12.1M12.9M12.9M12.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.50-$0.34-$0.35-$0.51
 
 
 
 
 
EPS Diluted-$0.50-$0.34-$0.35-$0.51